冠状动脉旁路移植术后极早期出院不影响再入院或生存
单中心回顾性研究纳入2011至2018年6327例单纯CABG患者,按术后住院时间分为短住院(≤4天)与非短住院(>4天)组,经倾向性评分1:1匹配后各2286例。匹配分析显示两组30天、1年、5年生存率及再入院率均无显著差异,短住院组卒中、肾衰竭、再手术及新发房颤发生率更低。结论认为CABG术后4天内极早期出院安全,对后续死亡或再入院风险无实质影响。
要点
- CABG术后≤4天出院与>4天出院相比,30天至5年生存率及再入院率均无显著差异。
- 短住院组术后卒中、肾衰竭、再手术及新发房颤发生率均显著低于非短住院组。
- 匹配队列平均STS预测手术死亡风险为0.7%,提示极早期出院结论适用于低风险人群。
核心结论
- 单纯CABG术后4天内极早期出院安全,对后续死亡或再入院风险无实质影响。
研究设计与样本
- 单中心回顾性队列研究,纳入2011至2018年接受单纯CABG的成人患者共6327例。
- 按术后住院时间分为短住院(≤4天)与非短住院(>4天)组,行1:1倾向性评分匹配生成2286例匹配队列。
主要发现
- 匹配队列平均STS预测手术死亡风险为0.7%。
- 短住院组与非短住院组卒中发生率分别为1.14%与0.26%(P = .01)。
- 短住院组与非短住院组肾衰竭发生率分别为0.87%与0.09%(P = .007)。
- 短住院组与非短住院组再手术率分别为1.84%与0.26%(P < .001)。
- 短住院组与非短住院组新发房颤发生率分别为34.21%与13.04%(P < .001)。
关键数值与推荐
- 匹配组30天生存率短住院组99.56% vs 非短住院组99.21%,1年97.73% vs 97.46%,5年91.15% vs 92.48%,均P > .05。
- 各时间间期再入院率及心脏相关或心衰特异性再入院均无差异(均P > .05)。
- 风险校正分析证实上述 findings。
临床怎么用
- 对低风险(平均STS预测手术死亡风险0.7%)单纯CABG患者,术后4天内出院可作为安全策略考虑。
- 极早期出院决策需结合患者术后恢复情况,本研究未报告具体出院标准。
局限性
- 单中心回顾性设计,结论外推需谨慎。
- 匹配队列平均STS预测手术死亡风险低(0.7%),结果可能不适用于高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated the impact of very early hospital discharge after coronary artery bypass grafting (CABG) on subsequent readmission and survival. METHODS: Adults undergoing isolated CABG from 2011 to 2018 at a single institution were included. Patients were stratified on the basis of their postoperative length of hospital stay: short stay (≤4 days) and nonshort stay (>4 days). The primary outcomes were longitudinal survival and freedom from hospital readmission. Secondary outcomes included rates of postoperative complications. Propensity score matching with a 1:1 ratio was performed to generate cohorts with comparable baseline characteristics. RESULTS: A total of 6327 patients underwent CABG during the study period, and a matched cohort of 2286 patients was identified. In matched analysis, the average Society of Thoracic Surgeons predicted risk of operative mortality was low in both groups (average, 0.7%). Rates of postoperative complications were low and several complication rates were even lower in the short-stay cohort: stroke (1.14% vs 0.26%; P = .01), renal failure (0.87% vs 0.09%; P = .007), reoperations (1.84% vs 0.26%; P < .001), and new-onset atrial fibrillation (34.21% vs 13.04%; P < .001). Survival was similar between the matched groups at 30 days (99.56% vs 99.21%), 1 year (97.73% vs 97.46%), and 5 years (91.15% vs 92.48%) (all P > .05). Readmission rates were also comparable at all time intervals, and there were no differences in cardiac-related or heart failure-specific readmissions (all P > .05). Risk-adjusted analyses confirmed these findings. CONCLUSIONS: This study demonstrates that very early discharge within 4 days of isolated CABG is safe and has no substantial impact on subsequent mortality or readmission risk.
引用
- Afflu DK, Seese L, Sultan I, et al. Very Early Discharge After Coronary Artery Bypass Grafting Does Not Affect Readmission or Survival. Ann Thorac Surg. 2020. PMID: 32745515. doi:10.1016/j.athoracsur.2020.05.159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。